The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
Ataman, Ozlem U
The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective. [electronic resource] - International journal of radiation oncology, biology, physics Nov 2012 - e447-54 p. digital
Publication Type: Journal Article; Review
1879-355X
10.1016/j.ijrobp.2012.05.019 doi
Clinical Trials as Topic--statistics & numerical data
Clinical Trials, Phase I as Topic--statistics & numerical data
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Combined Modality Therapy--methods
Drug Industry--statistics & numerical data
Humans
Molecular Targeted Therapy--methods
Neoplasms--mortality
Radiotherapy--methods
Research Support as Topic--statistics & numerical data
The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective. [electronic resource] - International journal of radiation oncology, biology, physics Nov 2012 - e447-54 p. digital
Publication Type: Journal Article; Review
1879-355X
10.1016/j.ijrobp.2012.05.019 doi
Clinical Trials as Topic--statistics & numerical data
Clinical Trials, Phase I as Topic--statistics & numerical data
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Combined Modality Therapy--methods
Drug Industry--statistics & numerical data
Humans
Molecular Targeted Therapy--methods
Neoplasms--mortality
Radiotherapy--methods
Research Support as Topic--statistics & numerical data